4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Liu, Y; Wang, S; Wang, Z; Yin, W | 1 |
1 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Cirrhosis
| Article | Year |
|---|---|
Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis.
Topics: Animals; Antioxidants; Benzamides; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Dietary Sucrose; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Kidney; Male; Matrix Metalloproteinase 2; NADPH Oxidase 4; Organophosphorus Compounds; Oxidative Stress; Reactive Oxygen Species; Swine; Swine, Miniature; Transforming Growth Factor beta1 | 2020 |